TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway

Dysregulation of TRIM32 has been implicated in several human cancers, however, its clinical significance and biological function in breast cancer have not been investigated. Using immunohistochemistry, we found that TRIM32 expression is upregulated in breast cancer tissues and that it correlates wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ting-Ting, Jin, Feng, Li, Ji-Guang, Xu, Ying-Ying, Dong, Hui-Ting, Liu, Qun, Xing, Peng, Zhu, Guo-Lian, Xu, Hao, Yin, Song-Cheng, Miao, Zhi-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929078/
https://www.ncbi.nlm.nih.gov/pubmed/29721043
http://dx.doi.org/10.7150/jca.22390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929078/
https://www.ncbi.nlm.nih.gov/pubmed/29721043
http://dx.doi.org/10.7150/jca.22390

Ejemplares similares